SEARCH

CATEGORIES

Upcoming Events Podcasts On demand
Bone health Gout JIA Lupus Medicines Medicopolitical Musculoskeletal Osteoarthritis Pain Psoriatic arthritis Public health Rare diseases Research Rheumatoid arthritis Risk factors Scleroderma Spondyloarthritis

About

About the limbic Contact Website Disclaimer Privacy Policy Terms & Conditions

Search

POSTS: Contrast dye shortage: Avoid CT scan requests ‘wherever feasible’, specialists urged

Medicines

Aussie app assesses hand arthritis as accurately as a rheumatologist

Arthritis drugs in PBS ‘limbo’ due to bureaucratic delays

Medicines

Consider reactive TDM for biologics in inflammatory arthritis: EULAR

Rheumatoid arthritis

There is no place for ‘diagnosis of exclusion’ in rheumatology: opinion

Rheumatoid arthritis

Contrast dye shortage: Avoid CT scan requests ‘wherever feasible’, specialists urged

Musculoskeletal

MORE NEWS

Australian guidance issued for tapering b/tsDMARDs in inflammatory arthritis

News in brief: Paradigm shift needed in assessment of PMR patients; Anakinra repurposed to prevent chemo-induced inflammation; Medical acronyms mystify patients

Specialist trainees ‘limiting family size’ to fit program rules

COVID-19

NZ Medical Association faces collapse due to plummeting membership

Rural vs city doctors: Who has had the most stressful pandemic?

Doctors health

‘Great journey ahead’ for JAK inhibitors in rheumatic conditions: BSR 2022

Medicines

EULAR’s 4 points to consider on telehealth

Stem cell potential for children with severe autoimmune diseases: review

News in brief: IV abatacept supplies restored; 3 ways to reduce carbon footprint from diagnostic imaging; Genetic scores predict joint replacements 

Corporate watchdog closes investigation into the RACP

Medical politics

bDMARD prescribing letters sent to rheumatologists strictly educational, says ARA

Medicines

News in brief: Is it time to get rid of the term ‘elective surgery’?; ‘The system has failed’: Qld health minister pledges cash to stop RHD deaths; NPS MedicineWise calls for review on its funding

Research

more news